Emerging mumps infection

Pediatric Infectious Disease Journal

Volumn 35, Issue 7, 2016, Pages 799-801

  Rubin, Steven ^a   Kennedy, Richard ^b   Poland, Gregory ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUMPS VACCINE; NEUTRALIZING ANTIBODY;

ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; EPIDEMIC; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; MUMPS; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION; COMMUNICABLE DISEASES, EMERGING; EPIDEMIOLOGICAL MONITORING; STATISTICS AND NUMERICAL DATA; UNITED STATES; VIROLOGY;

COMMUNICABLE DISEASES, EMERGING; EPIDEMIOLOGICAL MONITORING; HUMANS; MUMPS; MUMPS VACCINE; UNITED STATES; VACCINATION;

EID: 84964329682     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000001182     Document Type: Article

References (11)

1. Weibel RE, Stokes J Jr, Buynak EB, et al. Live attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation. N Engl J Med. 1967;276:245-251.
2. Rota JS, Rosen JB, Doll MK, et al. Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009. Clin Vaccine Immunol. 2013;20:391-396.
3. Cortese MM, Jordan HT, Curns AT, et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis. 2008;46:1172-1180.
4. Rubin SA, Link MA, Sauder CJ, et al. Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol. 2012;86:615-620.
5. Latner DR, McGrew M, Williams N, et al. Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosis. Clin Vaccine Immunol. 2011;18:35-42.
6. Kontio M, Jokinen S, Paunio M, et al. Waning antibody levels and avidity: implications for MMR vaccine-induced protection. J Infect Dis. 2012;206:1542-1548.
7. Homan EJ, Bremel RD. Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes?: An immunoinformatic analysis. Hum Vaccin Immunother. 2014;10:290-300.
8. Poland GA, Kennedy RB, McKinney BA, et al. Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century. Semin Immunol. 2013;25:89-103.
9. Fiebelkorn AP, Coleman LA, Belongia EA, et al. Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccine. Open Forum Infect Dis. 2014;1:ofu094.
10. Nelson GE, Aguon A, Valencia E, et al. Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control-Guam 2009 to 2010. Pediatr Infect Dis J. 2013;32:374-380.
11. Ogbuanu IU, Kutty PK, Hudson JM, et al. Impact of a third dose of measles-mumpsrubella vaccine on a mumps outbreak. Pediatrics. 2012;130:e1567-e1574.